Affiliation:
1. Postgraduate Final Year
2. Associate Professor, Dept Of DVL.
3. Associate Professor, Dept Of Biochemistry.
Abstract
Introduction:
Metabolic syndrome is a cluster of metabolic risk factors which includes central obesity, glucose intolerance, hyperinsulinemia, low HDL cholesterol, high triglycerides and hypertension. Acanthosis nigricans, the principal abnormality in metabolic syndrome (MetS), is an easily identifiable asymptomatic non-specific reaction pattern of skin characterized by thickened, hyperpigmented plaques associated with hyperinsulinemia.
Aims and Objectives:
To determine the prevalence of metabolic syndrome and AN in adolescent and adults and the association between benign acquired AN and metabolic syndrome.
Materials and Methods:
A sample of 40 patients selected from Dermatology outpatient department who satisfied the selection criteria to evaluate the prevalence of AN and its association with insulin resistance and the clustering of the MetS components. Epidemiological, clinical and anthropometric characteristics (height, weight, waist circumference) were measured and BMI was calculated. We used the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria for the diagnosis of metabolic syndrome.
Results:
The average age of the study population was 26.8 years, with male to female ratio of 1:1. The prevalence of acanthosis nigricans among females is greater than males, which also showed a positive correlation with increase in the age. BMI was higher in patients with metabolic syndrome than the patients without metabolic syndrome.There was a statistically significant correlation of increasing incidence of AN with each component of metabolic syndrome.
Conclusion:
There is an increased prevalence of MetS in the individuals with AN which was statistically highly significant. Hence, early screening of a simple clinical marker like AN is helpful in identification of MetS components.
Reference21 articles.
1. 1. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care 1999;22:1655‐9.
2. 2. Brickman WJ, Binns HJ, Jovanovic BD, Kolesky S, Mancini AJ, Metzger BE. Acanthosis nigricans: A common finding in overweight youth. Pediatr Dermatol 2007;24:601‐6.
3. 3. Otto DE, Wang X, Garza V, Fuentes LA, Rodriguez MC, Sullivan P. Increasing body mass index, blood pressure, and acanthosis nigricans abnormalities in school‐age children. J SchNurs 2013;29:442‐51.
4. 4. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31:1‐9.
5. 5. Balaji C, Vindhya M, Gurukul S. Significance of acanthosis nigricans as marker for metabolic syndrome. World J Med Sci 2014;10:295‐8.